A new drug intended to make it easier to clear mucus from the lungs of people with cystic fibrosis showed promising results in a Phase 2 clinical trial. The drug, called SPX-101, blocks the overactive sodium channels that line CF lung cells.
Site Search
Showing 11 - 20 of 115 results
News
|
June 7, 2018
|
2 min read
Today Vertex Pharmaceuticals Inc. announced the two next-generation CFTR modulator candidates that will progress into Phase 3 clinical trials.
News
|
Jan. 31, 2018
|
4 min read
News
|
Sept. 14, 2011
|
2 min read
Yesterday, President Donald J. Trump signed the Right to Try bill into law. The House approved the bill last week and the Senate passed it last summer.
News
|
May 31, 2018
|
3 min read
The Cystic Fibrosis Foundation's Greater New York Chapter recently recognized leading journalist Scott Pelley at the 14th annual Breath of Life Gala for his unwavering dedication to those living with CF.
News
|
Dec. 19, 2017
|
2 min read
News
|
Sept. 26, 2008
|
1 min read
News
|
June 29, 2009
|
1 min read
News
|
July 16, 2009
|
2 min read
News
|
Jan. 20, 2010
|
1 min read
The Cystic Fibrosis Foundation recently signed on to a letter with more than 70 organizations in opposition to the Right to Try Act, which passed in the House of Representatives earlier this month.
News
|
April 5, 2018
|
3 min read